Skip to main content
Premium Trial:

Request an Annual Quote

CORRECTION: Gates Foundation, Synlogic Collaborate On Technology Application

GenomeWeb Daily News was provided incorrect information that the $5 million was in addition to the $29.4 million that Synlogic raised in July. The summer financing included the $5 million.

NEW YORK (GenomeWeb) – Synthetic biology firm Synlogic today announced it and the Bill & Melinda Gates Foundation will collaborate as part of a $5 million investment from the foundation into Synlogic's Series A financing round in July that raised $29.4 million.

Synlogic previously announced that Atlas Venture and New Enterprise Associates invested in the Series A round. The Cambridge, Mass.-based firm today said that along with developing its technology platform and therapeutic applications, it will collaborate with the Gates Foundation on applications for its technology that are relevant to the developing world.

Synlogic's technology is based on bacteria that sense physiologic changes, perform a therapeutic action, and then deactivate themselves. In a statement, Trevor Mundel, president of global health for the Gates Foundation, said that the firm's technology could result in new therapies for the most severe diarrheal diseases, the second-leading cause of death for children in developing nations.

Synlogic also announced Paul Miller has joined the company as CSO and Alison Silva has joined it as Chief Operating Officer.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.